Attending the #AACR meeting for the first time and feeling excited to learn about the latest in cancer research. This conference provides a great opportunity to explore how we can leverage clinical trial diversity for better patient outcomes. Looking forward to sharing insights with fellow attendees! #CancerResearch #ClinicalTrials #DiversityAndInclusion VK Gadi, MD PhD Cecilia Zapata-Harms Lillia Holmes John H. Stewart IV, MD,MBA Marvella Ford
关于我们
At Equi Sciences CRO, we are committed to breaking the barriers of clinical trials inequity through medical research in which the rich tapestry of human diversity is represented. We work hard to ensure that all communities, regardless of race, ethnicity, gender identity, and socioeconomic status have equitable access to and participate in cutting-edge clinical trials.
- 网站
-
https://equisciences.com
Equi Sciences CRO的外部链接
- 所属行业
- 研究服务
- 规模
- 2-10 人
- 类型
- 私人持股
- 创立
- 2023
- 领域
- clinical research、data analytics、oncology和cardiology
动态
-
Our work at Equi Sciences CRO is exactly this. Educating our underserved communities about the importance of clinical research and improving the access and enrollments of ethnic patient participation that saves lives. #clinicaltrials #healthaccess #healthequity Serge Afeli, PhD, MSHA Lillia Holmes Cecilia Zapata-Harms
THE WORLD’S LONGEST LIVING IMATINIB & Tyrosine Kinase Inhibitor (TKI) & Kinase Inhibitor Survivor! Patient Advocate, 30 Year Terminal CML Leukemia Survivor, Clinical Trials, Major US Army Retired, ΩΨΦ
“Clinical trials are a way of getting tomorrow’s medicine today.”
-
We are excited to launch Equi Sciences CRO. We are a contract research organization committed to increasing diversity inclusion in clinical research. #clinicalresearch #diversity #healthcareaccess
Equi Sciences
equisciences.com